Olema Pharmaceuticals Closes $209 Million Initial Public Offering with Support from CFGI
CFGI’s Capital Markets team supported Olema Pharmaceuticals (Nasdaq: OLMA) with an initial public offering of 11,000,000 shares of common stock priced at $19.
How Does U.S. Tax Policy Change after U.S. Elections?
How will it impact you? President-Elect Joe Biden has often argued the Tax Cuts and Jobs Act (TCJA) was skewed to large corporations and upper-income individuals and that the U.
Matt Estadt Jumpstarts CFGI’s Transaction Advisory Services
If you want to succeed in the transaction services field, you need to stand out.
SEC Amends Rules Related to Acquisitions and Dispositions of Businesses
On May 20, 2020, the Securities and Exchange Commission (SEC) issued a final rule that amends the financial reporting requirements for acquisitions and dispositions of businesses, including the related pro forma reporting requirements.
Deal Disruption: How to Still Make 1 + 1 = 3
Times of uncertainty can present opportunities to think about M&A differently.
You Are Going Public, Now What? A Guide to Preparing the CFO Organization
The IPO is a critical inflection point for your organization, marking a crucial shift in expectations for the business.
FASB simplifies issuer’s accounting for certain debt and equity instruments through the elimination of the ‘beneficial conversion feature’ and ‘cash conversion feature’ separation models and changes to equity classification criteria
Summary The FASB has simplified the accounting for convertible debt and equity instruments and contracts issued in an entity’s own equity with the issuance of ASU 2020-06.
Vital Farms Closes $111 Million Initial Public Offering with Support from CFGI
CFGI’s Capital Markets team supported Vital Farms (Nasdaq: VITL) with an initial public offering of 5,040,323 shares of common stock priced at $22.